Navigation Links
Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction
Date:7/14/2014

stcor operate; the commercial success of Mallinckrodt's and Questcor's products, including H.P. Acthar® Gel; Mallinckrodt's and Questcor's ability to protect intellectual property rights; the parties' ability to satisfy the merger agreement conditions and consummate the merger on the anticipated timeline or at all; the availability of financing, including the financing contemplated by the debt commitment letter, on anticipated terms or at all; Mallinckrodt's ability to successfully integrate Questcor's operations and employees with Mallinckrodt's existing business; the ability to realize anticipated growth, synergies and cost savings; Questcor's performance and maintenance of important business relationships; the lack of patent protection for Acthar, and the possible United States Food and Drug Administration ("FDA") approval and market introduction of additional competitive products; Questcor's reliance on Acthar for substantially all of its net sales and profits; Questcor's ability to continue to generate revenue from sales of Acthar to treat on-label indications associated with nephrotic syndrome, multiple sclerosis, infantile spasms or rheumatology-related conditions, and Questcor's ability to develop other therapeutic uses for Acthar; volatility in Questcor's Acthar shipments, estimated channel inventory, and end-user demand; an increase in the proportion of Questcor's Acthar unit sales comprised of Medicaid-eligible patients and government entities; Questcor's research and development risks, including risks associated with Questcor's work in the areas of nephrotic syndrome and lupus, and Questcor's efforts to develop and obtain FDA approval of Synacthen Depot; Mallinckrodt's ability to receive procurement and production quotas granted by the U.S. Drug Enforcement Administration; Mallinckrodt's ability to obtain and/or timely transport molybdenum-99 to its technetium-99m generator production facilities; customer concentration;
'/>"/>
SOURCE Mallinckrodt plc
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. FDA Grants Priority Review To New Drug Application For MNK-795 Submitted By Depomed Licensee Mallinckrodt
2. Abbott to Sell its Developed Markets Branded Generics Pharmaceuticals Business to Mylan
3. Rock Creek Pharmaceuticals Issues Update On US Investigational New Drug Application
4. Valeant Pharmaceuticals Completes Sale Of Filler And Toxin Assets To Galderma
5. Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc.
6. Isis Pharmaceuticals to Receive $7.5 Million from Alnylam
7. Cadence Pharmaceuticals Estimates Fourth Quarter and Full Year 2013 Product Revenue and Provides Full Year 2014 Revenue Guidance
8. Jazz Pharmaceuticals Announces Acquisition From Aerial Biopharma Of Rights To A Late Stage Investigational Compound For Excessive Daytime Sleepiness
9. Avanir Pharmaceuticals Pre-announces Preliminary Fiscal 2014 First Quarter Financial Information
10. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Aegerion Pharmaceuticals, Inc.
11. Crealta Pharmaceuticals LLC Announces Completion of the Acquisition of Substantially All of the Assets of Savient Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... -- BGI a annoncé aujourd,hui que son laboratoire ... à Hong Kong avait ...  (Collège des pathologistes américains, ou CAP). Les installations ... constituent le premier laboratoire clinique de séquençage ... CAP en Chine, car il satisfait les normes ...
(Date:7/2/2015)... 2, 2015  New product launches are critical events ... in educating thought leaders about new products, Medical Affairs ... how well a new therapy performs at launch. ... and consulting leader Best Practices, LLC, critical aspects of ... on are early stage thought leader (TL) interaction, successful ...
(Date:7/2/2015)... 2, 2015 Roche,s Bloodhound technology is ... segment in hematology testing, according to Kalorama Information.  ... unveiling of its Bloodhound digital cell imaging technology ... 511 hematology analyzer – is notable as ... by current leader CellaVision, but also compete more ...
Breaking Medicine Technology:BGI obtient la certification du Collège des pathologistes américains (CAP) 2Medical Affairs Role in Thought Leader Education is Key Success Factor for New Product Launches in the Pharmaceutical Industry 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 3
... today visited the future site of Endo Pharmaceutical,s corporate headquarters ... continued commitment to the region and its plans to create ... Pennsylvania we are employing the kind of creative cooperation that ... ribbon on a new headquarters," said Corbett. "This investment in ...
... FISHKILL, N.Y., Jan. 17, 2012  Nano Mask, Inc. (NMI) (Pink ... company focused on emergency and critical care as well as ... sales, marketing and distribution office in Riyadh, Saudi Arabia to ... into the strong demand for its products in the region. ...
Cached Medicine Technology:Nano Mask Opens Office in Riyadh, Saudi Arabia Due to Strong Demand for Company's Products 2
(Date:7/3/2015)... ... July 03, 2015 , ... On ... for a new SEO training system called "Page One Engine" . The ... generation has received glowing reviews from several well-known marketers. HonestyFirstReviews.com's Tiffany Hendricks has ...
(Date:7/3/2015)... , ... July 03, 2015 , ... ... to healthcare providers, has been retained to lead a national president recruitment ... search firms in the healthcare industry, B. E. Smith has recently placed more ...
(Date:7/3/2015)... Louis, MO (PRWEB) , ... July 03, 2015 , ... ... responsive website to replace their existing Talcum Powder Cancer Lawsuit Center website. Just as ... talcum powder lawsuit news , offering timely lawsuit updates and ovarian cancer warning ...
(Date:7/3/2015)... ... July 03, 2015 , ... Yisrayl Hawkins, Pastor and Overseer at The ... he says will reveal biblical truth and expose popular lies regarding proper relationships according ... Don’t Have Sex”, immediately goes into the core of the subject by explaining why ...
(Date:7/2/2015)... ... ... Enterprises, LLC. is pleased to announce the opening of its newest location in Dallas, Texas. ... premium frozen yogurt chain was listed as #22 on the Inc. 500 list of fastest ... Bachman Lake, is located at:, 3701 W. Northwest Highway, STE 430, Dallas, TX 75220 , ...
Breaking Medicine News(10 mins):Health News:Page One Engine - Review Of Dori Friend's SEO Training Course Released 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 3Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:sweetFrog Opens 18th Location in the Lone Star State 2
... benefit in study of those with spinal afflictions, ... osteoporosis patients with spinal fractures, vertebroplasty provides significant ... a new study. , Vertebroplasty involves injection ... to shore up the fracture and provide pain ...
... ACM, one of the country,s leading,healthcare ... Plans, Inc. today announced a new agreement ... pricing precision to medical,pharmacy infusion services provided ... a decade, ACM,s e-Precision Claims(SM) technology has ...
... the SCIAMACHY instrument aboard ESA,s Envisat environmental satellite, scientists ... carbon dioxide the most important greenhouse gas that ... , More than 30 billion tonnes of extra carbon ... annually by human activities, mainly through the burning of ...
... St. John Hospital and Medical Center are recognized ... hospitals by one of the country,s leading,sources of ... from Thomson (formally Solucient), recognizes hospitals,that achieve or ... and SJH&MC were two of only 15 hospitals ...
... scientists from North Carolina State University have shown that ... reduces harmful carcinogens in cured tobacco leaves. , The ... products with reduced amounts of cancer-causing agents. , ... and Dr. Ramsey Lewis, assistant professor of crop science, ...
... may improve the health of patients with rheumatoid ... medical universit Karolinska Institutet. The diet has a ... disease. , Rheumatoid arthritis is associated with an ... and cardiovascular diseases. The underlying causes are unknown, ...
Cached Medicine News:Health News:Pain Relief for Osteoporosis Patients With Fractures 2Health News:ACM Partners With Tufts Associated Health Plans to Improve the Cost-effective Delivery of Home Infusion Services 2Health News:Envisat makes first ever observation of regionally elevated CO2 from manmade emissions 2Health News:Envisat makes first ever observation of regionally elevated CO2 from manmade emissions 3Health News:St. John Health Hospitals Honored as Nation's Top 15 Major Teaching Hospitals 2Health News:Gene 'knockout' floors tobacco carcinogen 2
... System combines the flexibility of polyaxial screws ... a single system. The result is ... loading to the vertebral anatomy, thus reducing ... polyaxial screws and lateral connectors reduces the ...
... The Equation System incorporates a semi-rigid design ... System is a reduced-volume and top-tightening spinal ... of fixation that mimics the load distribution ... designed to share, not bear, the load). ...
... System is a comprehensive and versatile hook, ... used for both deformity and degenerative cases. ... spine in 3-dimensions, the ISOLA/VSP Spine System ... correctly align and stabilize the spine. In ...
Multiwindow transcranial and peripheral Doppler system....
Medicine Products: